Not only is nonalcoholic steatohepatitis (NASH) the most common chronic liver condition worldwide, but it’s also becoming the number one cause of liver transplantation beyond hepatitis C. And with its growing prevalence and burden having no end in sight, Dr. Charles Turck speaks with Dr. Kenneth Cusi about how we can better recognize the symptoms of NASH in high-risk patient groups.